Portal de Periódicos da CAPES

Standards of care: The value and importance of standardization

1997; Wiley; Volume: 40; Issue: 3 Linguagem: Inglês

10.1002/art.1780400303

1529-0131

Josef S Smolen, G Steiner, Eng M. Tan,

Health Systems, Economic Evaluations, Quality of Life

Arthritis & RheumatismVolume 40, Issue 3 p. 410-412 EditorialFree to Read Standards of care: The value and importance of standardization Josef S. Smolen MD, Corresponding Author Josef S. Smolen MD University of Vienna and Ludwig Boltzmann Institute for Rheumatology Research, Vienna, Austria, Chair, IUIS Standardization Committee, and Chair, EULAR Standing Committee for International Clinical StudiesDepartment of Rheumatology, Internal Medicine III, General Hospital, Waehringer Guertel 18-20, A-1090 Vienna, AustriaSearch for more papers by this authorGünter Steiner MD, Günter Steiner MD University of Vienna and Ludwig Boltzmann Institute for Rheumatology ResearchSearch for more papers by this authorEng M. Tan MD, Eng M. Tan MD Scripps Research Institute, La Jolla, California, and Chair, WHO/IUIS/AF/CDC ANA Standardization CommitteeSearch for more papers by this author Josef S. Smolen MD, Corresponding Author Josef S. Smolen MD University of Vienna and Ludwig Boltzmann Institute for Rheumatology Research, Vienna, Austria, Chair, IUIS Standardization Committee, and Chair, EULAR Standing Committee for International Clinical StudiesDepartment of Rheumatology, Internal Medicine III, General Hospital, Waehringer Guertel 18-20, A-1090 Vienna, AustriaSearch for more papers by this authorGünter Steiner MD, Günter Steiner MD University of Vienna and Ludwig Boltzmann Institute for Rheumatology ResearchSearch for more papers by this authorEng M. Tan MD, Eng M. Tan MD Scripps Research Institute, La Jolla, California, and Chair, WHO/IUIS/AF/CDC ANA Standardization CommitteeSearch for more papers by this author First published: 12 December 2005 https://doi.org/10.1002/art.1780400303Citations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Appendices: In, Primer on the Rheumatic Diseases. Tenth edition. Edited by HR Schumacher, JH Klippel, WJ Koopman. Atlanta, Arthritis Foundation, 1993 2 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324, 1988 3 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277, 1982 4 Von Mühlen CA, Tan EM: Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24: 323–358, 1995 5 Schur PH, Sandson J: Immmunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 278: 533–538, 1968 6 Kallenberg CGM, Brouwer E, Weening TJ, Tervaert JW: Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiologic potential. Kidney Int 46: 1–15, 1994 7 Ekins R: Immunoassay standardization: phantasies, fallacies and facts. Scand J Clin Lab Invest 51 (Suppl 205): 33–36, 1991 8 Pesce AJ, Michael GJ: Artifacts and limitations of enzyme immunoassays. J Immunol Methods 150: 111–119, 1992 9 Tan EM, Fritzler MJ, Mc Dougal JS, McDuffie FC, Nakamura RM, Reichlin M, Reimer CB, Sharp GC, Schur PH, Wilson MR, Winchester RJ: Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum 25: 1003–1005, 1982 10 Tan EM, Feltkamp TEW, Alarcon-Segovia D, Dawkins RL, Homma M, Kalden JR, Lambert PH, Lange A, Maini RN, McDuffie FC, McDougal JS, Norberg R, Wilson M: Reference reagents for antinuclear antibodies (letter). Arthritis Rheum 31: 1331, 1988 11 Smolen JS, Butcher B, Fritzler MJ, Gordon T, Hardin J, Kalden JR, Lahita R, Maini RN, Reeves W, Reichlin M, Rothfield N, Takasaki Y, van Venrooij W, Tan EM: Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and Western blotting. Arthritis Rheum 40: 413–418, 1997 12 Maini RN, Smolen JS: Reports of the European Consensus Study Groups: preface. Clin Exp Rheumatol 10: 505–506, 1992 13 Charles PJ, van Venrooij WJ, Maini RN, and the Consensus Finding Group for Autoantibodies: The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases: 1989–1992. Clin Exp Rheumatol 10: 507–511, 1992 14 Zimmermann C, Smolen JS, Graninger W, Petera P, Fabini G, Hassfeld W, Höfler E, Steiner G: Fine specificity of anti-Ro (SSA) autoantibodies and clinical manifestations in patients with SLE. J Rheumatol 23: 1897–1903, 1996 15 Manual of Biological Markers of Disease. Edited by WJ van Venrooij, RN Maini. Dordrecht, The Netherlands, Kluwer Academic Publishers, 1994–1996 16 Arend WP, Dayer J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33: 305–315, 1990 17 Cytokines in Autoimmunity. Edited by M Feldmann, F Brennan. Austin, TX, RG Landes, 1996 18 Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105–1110, 1994 19 Roux-Lombard P, Steiner G, and the Cytokine Consensus Group of the European Workshop for Rheumatology Research: Preliminary report on cytokine determination in human synovial fluids: a consensus study of the European Workshop for Rheumatology Research. Clin Exp Rheumatol 10: 515–520, 1992 20 Mire-Sluis AR: Cytokines—protein structure and biological activities: a complex relationship with implications for biological assays and standardisation. Biologicals 21: 131–144, 1993 21 Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38: 727–735, 1995 22 Van Gestel AM, Preevo MLL, van't Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PLCM: Development and validation of the European League against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39: 34–40, 1996 Citing Literature Volume40, Issue3March 1997Pages 410-412 ReferencesRelatedInformation